Epidemiological studies generally have not found plasma total fibrinogen to be a risk factor for venous thromboembolism (VTE), but several have reported associations between variants in the fibrinogen gamma gene (FGG) and VTE. A case-control study in whites suggested plasma γ′ fibrinogen concentration may be associated inversely with VTE, but this was not replicated in African Americans. Objective To examine the prospective association between γ′ fibrinogen concentrations and occurrence of VTE. Methods We used the Longitudinal Investigation of Thromboembolism Etiology (LITE), involving two pooled population-based cohorts in the United States including 16,234 participants. The cohorts comprised white and African American men and women, aged 50 years and older at study onset in the early 1990s. We identified VTEs during follow-up and documented they met standardized diagnostic criteria. Results During two decades of follow-up, neither γ′ fibrinogen nor total fibrinogen nor their ratio was associated with VTE overall (n = 521 VTEs), in subgroups defined by race, or in other subgroups. In both race groups, the minor allele of FGG rs2066865 was associated with lower γ′ fibrinogen concentrations, but this allele was not associated with VTE. Conclusions A lower plasma concentration of γ′ fibrinogen in healthy adults does not appear to increase VTE risk.
Bibliographical noteFunding Information:
CHS was supported by contracts HHSN268201200036C , HHSN268200800007C , N01HC55222 , N01HC85079 , N01HC85080 , N01HC85081 , N01HC85082 , N01HC85083 , N01HC85086 , and grant U01HL080295 from the National Heart, Lung, and Blood Institute (NHLBI). Additional support was provided by R01AG023629 from the National Institute on Aging (NIA) . A full list of principal CHS investigators and institutions can be found at CHS-NHLBI.org .
- Fibrinogen gamma
- Prospective study
- Pulmonary embolus
- Venous thrombosis